Patients’ Baseline Characteristics
IBS group ( |
Non-IBS group ( |
||
---|---|---|---|
Age (yr) | 64.2 ± 6.3 | 66.7 ± 5.5 | 0.10 |
Sex (M/F) | 18/12 | 30/8 | 0.11 |
Cirrhosis etiology | |||
HBV | 2 (6.7) | 3 (7.8) | |
HCV | 16 (53.3) | 23 (60.5) | |
Alcohol | 4 (13.3) | 5 (13.2) | |
NASH/NAFLD | 3 (10.0) | 2 (5.3) | |
Others | 5 (16.7) | 5 (13.2) | |
Natural MELD at transplant (point) | 8 (5–30) | 10 (5–21) | 0.48 |
Locoregional bridge therapy | 23 (76.7) | 33 (86.8) | 0.344 |
TACE | 14 | 23 | |
RFA | 3 | 3 | |
Y90 | 0 | 1 | |
Combination | 9 | 4 | |
Nil | 4 | 7 | |
TTV (cm3) | 15.3 ± 17.6 | 11.5 ± 15.1 | 0.14 |
AFP (μg/L) | 10.8 (1.0–342.0) | 14.6 (2.0–3,395.0) | 0.53 |
HCC recurrence | 5 (16.7) | 1 (2.6) | 0.03* |